Organ-On-Chip Market Overview:
Organ-on-chip Market was valued at $5 million in 2016, and is expected to reach $170 million by 2023, registering a CAGR of 63.2% from 2017 to 2023. An organ-on-a-chip (OOC) is a microfluidic cell culture device, which is developed using microchip manufacturing methods that contain continuously perfused chambers inhabited by living cells arranged to simulate tissue- and organ-level physiology. This chip develops a narrow channel for the blood and air flow in organs such as lung, gut, liver, heart, and others. Such devices produce multiple levels of tissue and organ functionalities, which are not feasible using conventional 2D and 3D culture systems. Organ-on-chip offers a wide range of applications such as diseases modelling, patient stratification, and phenotypic screening.
The scope of organ-on-chip market includes potential opportunities for market players to enter the organ-on-chip market. The report provides in-depth market analysis of organ-on-chip market and outlines current trends, key driving factors, and potential areas for product investments.
The deployment modes of organ-on-chip devices applied in the industry are discussed in this report. The market is consolidated by the presence of major key players such as Emulate, Organovo, and others. The report highlights the competitive landscape of these players to increase their market shares and sustain the intense competition in the industry.
The global organ-on-chip market is segmented on the basis of type and geography. Based on type, the market is divided into heart-on-chip, human-on-chip, intestine-on-chip, kidney-on-chip, liver-on-chip, and lungs-on-chip. Geographically, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The heart-on-chip type has higher potential for growth in the global market. Lung-on-chip dominated the global market in 2016, and is expected to continue its dominance during the forecast period.
In 2016, North America held the largest market share, due to innovation in advanced technologies and increase in healthcare applications. Asia-Pacific is anticipated to witness the highest growth rate during forecast period, due to lucrative opportunities offered by countries such as China, India, and Japan.
Top Impacting Factors
Surge in applications of OOC devices in the healthcare sector, increase in demand for organ-on-chip in drug screening, rise in in demand for OOCs for lung- & kidney-based organ culture, high cost of OOC devices, nascent stage of R&D pertaining to OOCs, and increase in research activities on OOC devices are the significant factors that impact the growth of the global organ-on-chip market. These factors are anticipated to either drive or hamper the market.
Surge in Applications of Organ-on-chip Devices in the Healthcare Sector
Surge in demand for organ-on-chip devices in the healthcare industry is expected to boost the growth of the global market. Organ-on-chip devices are applicable in real-time imaging, in-vitro analysis of biochemical, and genetic & metabolic activities of living cells in a functional tissue, which significantly fuel their adoption.
Increase in Demand for Organ-on-chip in Drug Screening
Drug screening is a cost-effective method used for rapidly reviewing samples. Scientists and researchers use organ-on-chip culture devices to monitor the effects of drugs in the body. Furthermore, drug toxicity or drug effectiveness in various organs of the body is checked using this technique, which boosts the market growth.
Rise in Demand for Lung- & Kidney-based Organ Culture Devices
Shortage of donor lungs for transplantation has led to significant number of patient deaths. Thus, rise in demand to develop laboratory-engineered, functional organs is anticipated to supplement the growth of the market. Recellularized solid organs can perform organ-specific functions for short span of time, which indicates the potential for clinical use of engineered solid organs in the future.
Key Benefits for Stakeholders
- This study comprises analytical depiction of the global organ-on-chip market with current trends and future estimations to depict the imminent investment pockets.
- The overall market potential is determined to understand the profitable trends to gain a stronger foothold.
- The report presents information related to key drivers, restraints, and opportunities with a detailed impact analysis.
- The current market is quantitatively analyzed from 2016 to 2023 to highlight the financial competency of the market.
- Porter’s Five Forces analysis illustrates the potency of the buyers and suppliers in the industry.
Organ-On-Chip MarkeT Key Segments:
- North America
- Rest of Europe
- Rest of Asia-Pacific
- Latin America
- Middle East
Key Market Players Profiled
- Emulate, Inc.
- AxoSim Technologies LLC
- CN Bio Innovations
- Hurel Corporation
- Ascendance Biotechnology, Inc.
- Insphero AG
- Mimetas B.V.
- Nortis Inc.
- Organovo Holdings, Inc.
- Tara Biosystems